The largest database of trusted experimental protocols

Benchmark xt slide preparation system

Manufactured by Roche
Sourced in United States

The BenchMark XT Slide Preparation System is a laboratory equipment designed for the automated preparation of microscope slides. It performs tasks such as slide labeling, deparaffinization, and staining. The system is intended to streamline and standardize the slide preparation process in clinical and research settings.

Automatically generated - may contain errors

5 protocols using benchmark xt slide preparation system

1

Quantitative Immunohistochemical Analysis of Endometriotic Lesions

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the immunohistochemical studies, 3-μm-thick sections were cut from formalin-fixed, paraffin-embedded tissue blocks of endometriotic lesions and mounted on glass slides. The immunohistochemical analyses were performed using an automated Benchmark XT slide preparation system (Ventana Medical systems, Inc., Oro Valley, AZ, USA). Deparaffinization, epitope retrieval, and immunostaining were performed according to the manufacturer’s instructions by using cell-conditioning solutions (CC1) and the BMK ultraVIEW diaminobenzidine detection system (Ventana Medical Systems). The sections of the lesions were stained with RBP4 (1:500; Abcam). The positive signals were amplified using ultra-VIEW copper, and the sections were counterstained with hematoxylin and DAB. Images of the slides were captured using a Vectr intelligent Slide Analysis System (version 2.0.8, PerkinElmer Inc., Waltham, MA, USA). The images were subsequently used to train the Form Advanced Image Analysis Software (version 2.2, PerkinElmer Inc.) for quantitative image analysis.
+ Open protocol
+ Expand
2

Quantification of Tumor-Associated Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD68 and CD163 were used as TAM markers. Immunohistochemical (IHC) staining for CD68 and CD163 was performed using the BenchMark XT Slide Preparation System (Ventana Medical Systems, Tucson, AZ, USA) and CD68 (ready-to-use, 514H12, Novocastra, Newcastle upon Tyne, UK) and CD163 (1:200, 10D6, ER2, Novocastra). The proportion of CD163-positive area in each tumor was evaluated after IHC staining (Fig. 1). We divided the area of each tissue core into quarters and a central area and randomly chose all five fragments to determine the positive stain proportion (Fig. 1A). Areas of fibrosis or tumor necrosis among the randomly chosen fragments were excluded. We used a color deconvolution plug-in for Image J software to identify the positive stains and to calculate the percent CD163-positive area (Fig. 1B, C). TAM density was determined by calculating the average CD163-positive area (%) at a minimum of four different sites in each tissue.
+ Open protocol
+ Expand
3

Immunohistochemical Analysis of Tumor Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
The original tumor tissue and the explant of the tumor tissue were fixed in 10% neutral-buffered formalin and embedded in paraffin. Four microm sections were stained with H&E for the histological evaluation. For immunohistochemical analysis four micron paraffin sections were prepared, deparaffinized in xylene, and rehydrated with graded ethanol. Antigen retrieval was performed by microwave pretreatment. The following antibodies were employed for the analysis: Ki67 (clone 30-9, dilution, Ventana Medical Systems), p53 (clone DO-7, dilution 1:100, DAKO), p16ink4a (clone E6H4, dilution 1:50, MTM Laboratories), RB (clone 1F8, dilution 1:50, Thermoscientific), EGFR (clone 5B7 prediluted, Ventana Medical Systems) and cleaved caspase 3 (clone 5A1E, dilution 1:300, Cell Signaling). All stains were performed using the BenchMark XT Slide Preparation System (Ventana Medical Systems).
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of OCT4 Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
TMA blocks consisting of a representative tumor core section 2 mm in diameter from each formalin fixed paraffin block (SuperBioChips Laboratories, Seoul, Republic of Korea) were manufactured for IHC analysis. IHC staining was performed using the BenchMark XT Slide Preparation System (Ventana) and rabbit polyclonal anti-OCT4 antibody (1:100, Abcam, Cambridge, MA, USA). Assessments of the staining were evaluated under a light microscope by two experienced pathologists who did not know the exact condition of the patient and the scores were depended on staining intensity and proportion as previously described. For each tissue core, the intensity of staining was categorized as follows: 0, negative; 1 weak; 2 moderate; and 3, strong. And based on the proportion of staining, the degree was scored on a scale of 0 (< 5%, absent), 1 (5%–25%, sporadic), 2 (25%–50%, focal) and 3 (> 50%, diffuse). The final score of each staining was obtained by multiplying the two scores. The IHC score ranged from 0 to 9, which less than 4 points was determined to negativity.
+ Open protocol
+ Expand
5

Immunocytochemical Staining for CTC Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
For pathological confirmation and finding various types of CTCs, immunocytochemical staining was conducted for captured cells from blood samples donated by cancer patients with RCC independently. All captured and released cells from the microfilter were gently cytospinned on slide glass and fixed with 4% paraformaldehyde in 15 minutes. After fixation step, each slide were automatically immunostained by using the BenchMark XT Slide Preparation System (Ventana Medical Systems, Inc., Tucson, AZ, USA), with antibodies to EpCAM (clone VU-1D9, 1:2,000, Calbiochem, San Diego, CA, USA), CK (clone AE1/AE3, 1:100, Dako Cytomation, Glostrup, Denmark), and CD10 (clone 56C6, 1:400, Novocastra Leica Biosystems, NewCastle, UK). Positive expression was defined as the unequivocal brownish staining in the cytoplasm and/or cell membrane. Cytologic criteria for tumor cells were as follow: large cell size (1.5 times larger than white blood cells), large nuclear size with high nuclear-cytoplasmic ratio, irregular nuclear membrane, and presence of cytoplasm42 (link). The presence of tumor cells regardless of their EpCAM, CK (AE1/AE3), or CD10 expressions was considered as CTC, and the total number of CTCs in entire slide was enumerated. All slides were examined by one pathologist (Chang, H.J.).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!